Von Willebrand Disease
The most likely diagnosis is von Willebrand disease (VWD), given the constellation of lifelong mucocutaneous bleeding (easy bruising, menorrhagia since menarche), maternal history of bleeding disorder, post-procedural bleeding after dental extraction, prolonged aPTT with mildly decreased factor VIII activity, and normal platelet count. 1
Clinical Reasoning Algorithm
Step 1: Pattern Recognition of Bleeding Symptoms
- Mucocutaneous bleeding pattern is the hallmark of VWD, including easy bruising, heavy menstrual bleeding, nosebleeds, and bleeding after dental procedures 1
- This patient demonstrates the classic triad: lifelong bleeding history, menorrhagia since menarche, and post-procedural bleeding after wisdom tooth extraction 1
- The maternal history of bleeding disorder supports an autosomal inheritance pattern, which is characteristic of VWD affecting males and females equally 1
Step 2: Laboratory Profile Analysis
The laboratory findings definitively point toward VWD:
- Prolonged aPTT (51 seconds) with normal PT (11.5 seconds) indicates a defect in the intrinsic coagulation pathway 1
- Mildly decreased factor VIII activity (64%) occurs because VWF carries and stabilizes factor VIII in circulation; VWF deficiency leads to secondary factor VIII reduction 1, 2
- Normal platelet count (360) rules out immune thrombocytopenia 1
- Normal factor IX activity (90%) excludes hemophilia B 1
Step 3: Excluding Alternative Diagnoses
Disseminated Intravascular Coagulation (DIC):
- Ruled out by normal platelet count, normal PT, and absence of systemic illness 1
- DIC would show thrombocytopenia, prolonged PT and aPTT, and elevated D-dimer
Hemophilia A:
- Extremely unlikely in a female patient (X-linked recessive disorder) 1
- Would require homozygosity or Turner syndrome, neither suggested here
- Factor VIII at 64% is too high for symptomatic hemophilia A
Hemophilia B:
- Excluded by normal factor IX activity (90%) 1
Immune Thrombocytopenia:
- Excluded by normal platelet count (360) 1
Step 4: Understanding VWD Pathophysiology in This Case
VWD causes bleeding through dual mechanisms: 2
- Impaired platelet adhesion at sites of vascular injury (explaining mucosal bleeding, easy bruising, and post-extraction bleeding)
- Secondary factor VIII deficiency due to loss of VWF carrier function (explaining prolonged aPTT and mildly reduced factor VIII)
The factor VIII level of 64% is consistent with Type 1 VWD (partial quantitative VWF deficiency), which accounts for approximately 75% of symptomatic VWD cases 1
Critical Clinical Pearls
Common Pitfalls to Avoid:
- Do not dismiss VWD based on "borderline" factor VIII levels - levels between 50-70% are common in Type 1 VWD and still cause significant bleeding 1
- Do not confuse with hemophilia A - the female sex, mucocutaneous bleeding pattern, and family history through the maternal line all favor VWD over hemophilia 1
- Do not overlook the menorrhagia history - 5-20% of women with menorrhagia have previously undiagnosed VWD 3
Immediate Management Considerations:
Given the active post-extraction bleeding with hemoglobin of 9.2 g/dL (indicating significant blood loss):
- Desmopressin 0.3 μg/kg IV is first-line therapy for Type 1 VWD, raising endogenous VWF and factor VIII levels 3-6 fold within 30-90 minutes 4, 5, 6
- Local hemostatic measures including firm compression and resorbable packing materials 4
- Tranexamic acid as adjunctive antifibrinolytic therapy 6, 7
Next Diagnostic Steps:
Complete VWD workup requires: 8, 9
- VWF antigen levels (quantitative measurement)
- VWF activity assays (ristocetin cofactor activity or glycoprotein Ib binding)
- VWF multimer analysis for subtyping if Type 2 variants suspected
- Referral to hematology or hemophilia treatment center for definitive diagnosis and subtype classification 3